By Robb M. Stewart

Waters expects momentum in revenue and adjusted-earnings growth seen in the latest quarter to continue into 2026.

The maker of healthcare and science products recorded fourth-quarter net income of $225.2 million, or $3.77 a share, compared with $231.4 million, or $3.88 a year earlier. Waters' cost of sales and selling and administrative expenses were up in the latest period.

On an adjusted basis, per-share earnings rose to $4.53, just above the $4.51 mean estimate of analysts polled by FactSet.

Sales for the quarter rose 6.8% to $932.4 million from $872.7 million, where analysts expected $928.3 million for the three months. In constant currency terms, sales were up 6%.

The company said sales into the pharmaceutical market increased 8%, and 7% in constant currency. Sales into the industrial market increased 8%, but academic and government market sales decreased 2%.

For 2026, Water said it expects constant-currency revenue growth of between 5.5% and 7%. It projects revenue for the year in a $6.41 billion to $6.46 billion range.

Adjusted earnings for the year are expected to be between $14.30 and $14.50.

Write to Robb M. Stewart at robb.stewart@wsj.com

(END) Dow Jones Newswires

February 09, 2026 07:10 ET (12:10 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.